Three key oncogenes overexpressed in PAH were reduced in expression by pharmacological suppression of BRD4 using JQ1 or siBRD4: nuclear factor of activated T cells, B-cell lymphoma 2, and survivin. This evidence concerns the gene BRD4 and pulmonary arterial hypertension.